Mono Pharmacare share news and announcements

NSE: MONOPHARMAPharmaceuticals & Biotechnology

₹8.50₹0.40 (4.49%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹8.90.

52-week range of traded prices to 23 Oct 2026

₹7.50Low, 10 Aug 2026₹22.05High, 28 Nov 2025

Market cap: ₹15 Cr
P/E: 42.4
P/B: 0.5
Dividend yield: Nonein the last 12 months
ROE: 1.1%
Debt to equity: 1.79
Volume, NSE: 2,000100.0% delivered

Mono Pharmacare share news and announcements

110 announcements, routine notices left out, newest first. Page 2 of 3.

Sep 2025
- 9 Sep · Corporate action
  Record date for the purpose of MT is 24-Sep-2025. (opens in a new tab)
- 4 Sep · Meeting
  Notice of Annual General Meeting to be held on September 29, 2025 (opens in a new tab)
Aug 2025
- 26 Aug · Updates
  Board comments on fine levied by exchange (opens in a new tab)
- 26 Aug · Board meeting
  Board meeting held on August 26, 2025. (opens in a new tab)
- 12 Aug · Board meeting
  To consider other business matters (opens in a new tab)
Jun 2025
- 2 Jun · Updates
  Previous outcome of application no. 2025/May/116581/28975, stating that a clerical mistakes was identified in the standalone cash flow statement. This error has now been corrected through a revision. (opens in a new tab)
May 2025
- 31 May · Results
  Financial results for the period ended March 31, 2025. (opens in a new tab)
- 27 May · Board meeting
  Board meeting to be held on May 28, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2025, To consider and approve the financial results for the period ended March 31, 2025 and other business matters (opens in a new tab)
- 12 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2025 (opens in a new tab)
  Not held on this date
Apr 2025
- 10 Apr · Updates
  Cancellation of board meeting due to unforeseen circumstances (opens in a new tab)
- 4 Apr · Board meeting
  Board meeting to be held on April 02, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 11, 2025, To consider other business matters (opens in a new tab)
Mar 2025
- 29 Mar · Board meeting
  Board meeting to be held on April 02, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 05, 2025, To consider other business matters (opens in a new tab)
- 28 Mar · Board meeting
  To consider other business matters (opens in a new tab)
Feb 2025
- 10 Feb · Board meeting
  Board meeting held on February 10, 2025, Considered and approved appointment of Mr. Rahul Joshi (ACS- 66206) as company secretary & compliance officer of the company. (opens in a new tab)
- 8 Feb · Business
  Statement of deviation(s) or variation(s) under Reg. 32 (opens in a new tab)
- 1 Feb · Board meeting
  To consider other business matters i.e. To consider and approve the appointment of Mr. Rahul Joshi (ACS-66206) as a Group Company Secretary & Compliance Officer of Mono Pharmacare Limited. (opens in a new tab)
- 1 Feb · Updates
  Receipt of Consent letter and Brief profile for the post of Company secretary and Compliance officer of the Company (opens in a new tab)
- 1 Feb · Change in Company Secretary/Compliance Officer
  Change in Company Secretary/Compliance Officer and receipt of consent letter from the proposed Company Secretary/Compliance Officer of the Company. (opens in a new tab)
Jan 2025
Dec 2024
- 14 Dec · Updates
  'Corrigendum to the Announcement dated November 22, 2024 (App. No. 2024/Nov/17515/17753)' Receipt of Consent letter and Brief profile of Ms. Drashti Rohit Chande for appointment as Additional Independent Director of the Company (opens in a new tab)
- 12 Dec · Legal
  Exchange has sought clarification from Mono Pharmacare Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited. (opens in a new tab)
Nov 2024
- 22 Nov · Updates
  Reciept of Consent letter and Brief profile of Ms. Drashti Rohit Chande for appointment as Additional Independent Director of the Company. (opens in a new tab)
- 14 Nov · Results
  Financial results for the period ended September 30, 2024. (opens in a new tab)
- 14 Nov · Board meeting
  Board meeting held on November 14, 2024. (opens in a new tab)
- 6 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2024 and other business matters (opens in a new tab)
Oct 2024
- 21 Oct · Updates
  Non applicability of Corporate Governance for the Quarter ended September 30, 2024 (opens in a new tab)
- 2 Oct · Meeting
  Copy Srutinizers report of Annual General Meeting held on September 30, 2024. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
Sep 2024
- 30 Sep · Meeting
  Proceedings of Annual General Meeting held on September 30, 2024 (opens in a new tab)
- 7 Sep · Meeting
  Notice of Annual General Meeting to be held on September 30, 2024 (opens in a new tab)
- 6 Sep · Corporate action
  Record date for the purpose of Remote e-voting is 24-Sep-2024. (opens in a new tab)
- 6 Sep · Board meeting
  Board meeting held on September 06, 2024. (opens in a new tab)
Aug 2024
- 30 Aug · Board meeting
  To consider other business matters (opens in a new tab)
- 6 Aug · Board meeting
  Board meeting held on August 06, 2024. (opens in a new tab)
Jul 2024
- 30 Jul · Board meeting
  To take note of resignation of Mrs. Pooja Seth as Company Secretary and Compliance Officer of the Company and other business matters. (opens in a new tab)
- 27 Jul · Management
  Resignation of Mrs POOJA SETH as Company Secretary & Compliance Officer of the company w.e.f. July 26, 2024. (opens in a new tab)
- 26 Jul · Management
  Resignation of Mrs POOJA SETH as Company Secretary & Compliance Officer of the company w.e.f. July 26, 2024. (opens in a new tab)
- 13 Jul · Updates
  Non Applicability of Corporate Governance (opens in a new tab)
May 2024
- 31 May · Results
  Financial results for the period ended March 31, 2024. (opens in a new tab)
- 31 May · Board meeting
  Board meeting held on May 30, 2024. (opens in a new tab)
- 25 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2024 and other business matters (opens in a new tab)
Apr 2024
- 29 Apr · Board meeting
  Board meeting held on April 29, 2024. (opens in a new tab)
- 24 Apr · Board meeting
  To consider other business matters (opens in a new tab)
- 15 Apr · Updates
  NON APPLICABILITY OF CORPORATE GOVERNANCE (opens in a new tab)
Mar 2024
- 11 Mar · Board meeting
  To consider other business matters (opens in a new tab)
Jan 2024
- 20 Jan · Updates
  SDD compliance certificate for the Quarter ended 31 December 2023 (opens in a new tab)

Mono Pharmacare share news and announcements

Sep 2025

Aug 2025

Jun 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

May 2024

Apr 2024

Mar 2024

Jan 2024